SCHEMBL7143058

SCHEMBL7143058

COc1cc(NC(=O)OC(C)(C)C)c(N)cc1-c1ccccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 4/20 0.44
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
MAPT P10636 2/20 0.40
TSHR P16473 1/20 0.40
RAB9A P51151 1/20 0.40
ATM Q13315 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ABCB1 P08183 2/20 0.39
ABCC1 P33527 2/20 0.39
RXFP1 Q9HBX9 1/20 0.38
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144127 0.91 RXFP1 (0.38) AAK1RAB9ARXFP1POLBCHRM3
SCHEMBL7138096 0.88 AAK1 (0.43) AAK1ALDH1A1MAPTRAB9ASMN1; SMN2
SCHEMBL7144215 0.87 KDM4E (0.44) AAK1KDM4EALDH1A1RXFP1HDAC1
SCHEMBL6166077 0.86 RXFP1 (0.39) AAK1RXFP1POLBHDAC1
SCHEMBL7140411 0.85 HDAC1 (0.46) KDM4EALDH1A1RAB9AHDAC1KMT2A
SCHEMBL5562894 0.83 RXFP1 (0.38) AAK1RAB9ARXFP1POLBHDAC1
SCHEMBL25380050 0.83 AAK1 (0.47) AAK1KDM4EALDH1A1ABCB1ABCC1
SCHEMBL7143512 0.83 AAK1 (0.45) AAK1SMN1; SMN2ABCB1ABCC1HDAC1
SCHEMBL7141097 0.83 RAB9A (0.46) ALDH1A1MAPTTSHRRAB9ASMN1; SMN2
SCHEMBL7142641 0.82 AAK1 (0.43) AAK1ALDH1A1MAPTSMN1; SMN2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
EP-1224174-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2002-07-24 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed
WO-2001029011-A2 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-04-26 WO disclosed